The 2020 WHO classification of tumors of bone: an updated review

JH Choi, JY Ro - Advances in anatomic pathology, 2021 - journals.lww.com
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …

[HTML][HTML] Advances in immune checkpoint inhibitors for bone sarcoma therapy

P Thanindratarn, DC Dean, SD Nelson… - Journal of bone …, 2019 - Elsevier
Bone sarcomas are a collection of sporadic malignancies of mesenchymal origin. The most
common subtypes include osteosarcoma, Ewing sarcoma, chondrosarcoma, and chordoma …

Three-dimension-printed custom-made prosthetic reconstructions: from revision surgery to oncologic reconstructions

A Angelini, G Trovarelli, A Berizzi, E Pala… - International …, 2019 - Springer
Background The use of custom-made 3D-printed prostheses for reconstruction of severe
bone defects in selected cases is increasing. The aims of this study were to evaluate (1) the …

Novel therapeutic approaches in chondrosarcoma

G Polychronidou, V Karavasilis, SM Pollack… - Future …, 2017 - Taylor & Francis
Chondrosarcoma is a malignant tumor of bones, characterized by the production of cartilage
matrix. Due to lack of effective treatment for advanced disease, the clinical management of …

Chondrosarcoma-from molecular pathology to novel therapies

AE Zając, S Kopeć, B Szostakowski, MJ Spałek… - Cancers, 2021 - mdpi.com
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …

Infection after surgical resection for pelvic bone tumors: an analysis of 270 patients from one institution

A Angelini, G Drago, G Trovarelli, T Calabrò… - … and Related Research®, 2014 - Springer
Background Surgical treatment of pelvic tumors with or without acetabular involvement is
challenging. Primary goals of surgery include local control and maintenance of good quality …

Survival and prognostic factors in conventional central chondrosarcoma

J Fromm, A Klein, A Baur-Melnyk, T Knösel, L Lindner… - BMC cancer, 2018 - Springer
Background Chondrosarcoma is the second most frequent primary malignant bone tumor.
Treatment is mainly based on surgery. In general, wide resection is advocated at least in G2 …

Can machine-learning techniques be used for 5-year survival prediction of patients with chondrosarcoma?

QCBS Thio, AV Karhade, PT Ogink… - Clinical Orthopaedics …, 2018 - journals.lww.com
Background Several studies have identified prognostic factors for patients with
chondrosarcoma, but there are few studies investigating the accuracy of computationally …

The role of surgical margins in chondrosarcoma

JD Stevenson, MK Laitinen, MC Parry… - European Journal of …, 2018 - Elsevier
Introduction Chondrosarcoma (CS) is the second most common primary bone sarcoma with
no clear role for adjuvant therapy. The purpose of this study was to investigate (1) the …

The identification of prognostic factors and survival statistics of conventional central chondrosarcoma

SPFT Nota, Y Braun, JH Schwab, CN van Dijk… - Sarcoma, 2015 - Wiley Online Library
Introduction. Chondrosarcomas are malignant bone tumors that are characterized by the
production of chondroid tissue. Since radiation therapy and chemotherapy have limited …